Evidence map›Paper›PMID 32731629›Full record

ArticleMolecules (Basel, Switzerland)2020

Apoferritin and Apoferritin-Capped Metal Nanoparticles Inhibit Arginine Kinase of

Oluyomi Stephen Adeyemi, Afolake T Arowolo, Helal F Hetta, Salim Al-Rejaie, Damilare Rotimi, Gaber El-Saber Batiha

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 6 countries.

Oluyomi Stephen AdeyemiLaboratory of Theoretical and Computational Biophysics, Ton Duc Thang University, Ho Chi Minh City 758307, Vietnam.
Afolake T ArowoloHair and Skin Research Laboratory, Division of Dermatology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
Helal F HettaDepartment of Medical Microbiology and Immunology, Faculty of Medicine, Assiut University, Assiut 71515, Egypt.ORCID 0000-0001-8541-7304
Salim Al-RejaieDirector for KSU Human Resources, Department of Pharmacology & Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
Damilare RotimiNanomedicine & Toxicology Laboratory, Medicinal Biochemistry, Department of Biochemistry, Landmark University, PMB 1001, Omu-Aran 251101, Nigeria.ORCID 0000-0003-3721-8065
Gaber El-Saber BatihaDepartment of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, AlBeheira, Egypt.ORCID 0000-0002-7817-425X
Assiut University · EGDamanhour University · EGKing Saud University · SALandmark University · NGTon Duc Thang University · VNUniversity of Cape Town · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to explore the inhibitory potential of apoferritin or apoferritin-capped metal nanoparticles (silver, gold and platinum) against

Indexed as

ApoferritinsArginine KinaseMetal NanoparticlesProtozoan ProteinsTrypanocidal AgentsTrypanosoma brucei bruceiApoferritinsArginine KinaseProtozoan ProteinsTrypanocidal Agentsdrug discoverymedicinal biochemistrynanomedicineselective inhibitorstrypanosomiasis

Identifiers

PMID32731629
PMCPMC7435722
OpenAlexW3045858721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.